Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-free Treatment of Acute Genotype 1 Hepatitis C Virus Infection with Ledipasvir/Sofosbuvir
2013-001081-42Phase 2Completed
- Sponsor
- Hannover Medical School
- Start
- Jul 2014
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Harvoni in hepatitis C virus infection, sponsored by Hannover Medical School. Primary endpoint: SVR12. Started Jul 2014; status: completed.
02
Drugs
Harvoni
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2013-001081-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001081-42.